Published in Catheter Cardiovasc Interv on March 01, 2007
Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med (2008) 4.72
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet (2011) 4.59
A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol (2013) 4.46
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA (2007) 3.25
Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol (2004) 2.65
Balloon guide catheter improves revascularization and clinical outcomes with the Solitaire device: analysis of the North American Solitaire Acute Stroke Registry. Stroke (2013) 2.46
Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation (2012) 2.17
Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators. JACC Cardiovasc Interv (2011) 2.01
Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol (2006) 2.00
Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol (2004) 1.90
Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol (2006) 1.84
Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol (2005) 1.82
Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke (2008) 1.66
Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv (2012) 1.65
Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2009) 1.64
The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention. Stroke (2006) 1.64
Interventional cardiology perspective of functional tricuspid regurgitation. Circ Cardiovasc Interv (2009) 1.61
Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol (2005) 1.59
The transradial approach for carotid artery stenting. Catheter Cardiovasc Interv (2012) 1.53
Impact of aortic valve replacement on outcome of symptomatic patients with severe aortic stenosis with low gradient and preserved left ventricular ejection fraction. Circulation (2013) 1.51
Feasibility of simultaneous bilateral carotid artery stenting. Catheter Cardiovasc Interv (2004) 1.50
Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). Am J Cardiol (2005) 1.49
Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. J Am Coll Cardiol (2010) 1.49
Endovascular management of spontaneous carotid artery dissection. J Vasc Surg (2005) 1.48
Do bisphosphonates slow the progression of aortic stenosis? J Am Coll Cardiol (2012) 1.48
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting. J Am Coll Cardiol (2013) 1.48
Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial. Catheter Cardiovasc Interv (2011) 1.48
Effect of chronic kidney disease on outcomes after carotid artery stenting. Am J Cardiol (2004) 1.47
Heavy metals and cardiovascular disease: results from the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Angiology (2011) 1.46
Three-dimensional computed tomography in the cardiac catheterization laboratory. Catheter Cardiovasc Interv (2011) 1.46
Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation. JACC Cardiovasc Interv (2008) 1.44
Cutting balloon angioplasty to treat carotid in-stent restenosis. J Invasive Cardiol (2004) 1.42
Integration of MDCT and fluoroscopy using C-arm computed tomography to guide structural cardiac interventions in the cardiac catheterization laboratory. Catheter Cardiovasc Interv (2014) 1.42
Use of intraprocedural CT imaging to guide alcohol septal ablation of hypertrophic cardiomyopathy in the cardiac catheterization laboratory. Catheter Cardiovasc Interv (2012) 1.41
Percutaneous treatment of aortic valve stenosis. Cleve Clin J Med (2008) 1.41
Superficial femoral artery occlusion: nitinol stents achieve better flow and reduce the need for medications than balloon angioplasty alone. J Invasive Cardiol (2003) 1.41
Drug-eluting stents: the beginning of the end of restenosis? Cleve Clin J Med (2004) 1.41
Carotid stenting vs surgery: parsing the risk of stroke and MI. Cleve Clin J Med (2010) 1.41
Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump support. Heart (2010) 1.40
Catheter-based closure of paravalvular leak. Expert Rev Cardiovasc Ther (2014) 1.40
Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia. JACC Cardiovasc Interv (2009) 1.40
Nine-month results of the REFORM study: a prospective, single-arm, multicenter clinical study of the safety and effectiveness of the Formula™ balloon-expandable stent for treatment of renal artery stenosis. Catheter Cardiovasc Interv (2013) 1.40
Percutaneous closure of a postero-medial mitral paravalvular leak: the triple telescopic system. Catheter Cardiovasc Interv (2011) 1.39
Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center. Am J Cardiol (2005) 1.39
The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv (2007) 1.38
Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2008) 1.37
Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol (2002) 1.36
The nutcracker syndrome. Ann Vasc Surg (2011) 1.34
Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke (2005) 1.25
Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke (2005) 1.24
CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail (2011) 1.24
Rate, predictors, and consequences of hemodynamic depression after carotid artery stenting. J Am Coll Cardiol (2006) 1.17
Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review. Clin Cardiol (2013) 1.15
Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol (2013) 1.15
Drug-eluting stent fracture and acute coronary syndrome. Cardiovasc Revasc Med (2009) 1.14
Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol (2008) 1.12
Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation (2003) 1.12
The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv (2007) 1.12
Optimization of acquisition and contrast injection protocol for C-arm CT imaging in transcatheter aortic valve implantation: initial experience in a swine model. Int J Cardiovasc Imaging (2012) 1.09
Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function. J Investig Med (2004) 1.05
Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol (2013) 1.05
Aortic root morphology in patients undergoing percutaneous aortic valve replacement: evidence of aortic root remodeling. J Thorac Cardiovasc Surg (2009) 1.04
Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J (2011) 1.04
Rate of progression of coronary atherosclerotic plaque in women. J Am Coll Cardiol (2007) 1.03
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol (2013) 1.02
Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol (2012) 1.02
Endovascular treatment of carotid artery aneurysms with stent grafts. J Invasive Cardiol (2002) 1.02
Slow-flow phenomenon during carotid artery intervention with embolic protection devices: predictors and clinical outcome. J Am Coll Cardiol (2005) 0.98
Percutaneous paravalvular leak closure- imaging, techniques and outcomes. Circ J (2012) 0.98
Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J (2002) 0.98
Anterior ST-segment elevation with right coronary artery occlusion: a unique case of isolated right ventricular infarction. Angiology (2008) 0.96
Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: Preprocedural assessment with multidetector computed tomography. J Thorac Cardiovasc Surg (2009) 0.96
Endovascular repair of carotid artery aneurysm with Jostent covered stent: initial experience and one-year result. Catheter Cardiovasc Interv (2004) 0.95
Multicenter analysis of stenting in symptomatic intracranial atherosclerosis. Neurosurgery (2012) 0.94
Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling. Am J Cardiol (2002) 0.93
Pre-procedural imaging of aortic root orientation and dimensions: comparison between X-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography. JACC Cardiovasc Interv (2010) 0.93
Predictors of difficult carotid stenting as determined by aortic arch angiography. J Invasive Cardiol (2008) 0.92
Three-dimensional imaging of the aortic valve and aortic root with computed tomography: new standards in an era of transcatheter valve repair/implantation. Eur Heart J (2009) 0.92
Qualification requirements for performing neurointerventional procedures: a Report of the Practice Guidelines Committee of the American Society of Neuroimaging and the Society of Vascular and Interventional Neurology. J Neuroimaging (2008) 0.92
Clinical cerebrovascular anatomy. Catheter Cardiovasc Interv (2010) 0.92
Percutaneous treatment for pacemaker-associated superior vena cava syndrome. Pacing Clin Electrophysiol (2002) 0.91
The management of renal artery atherosclerosis for renal salvage: does stenting help? J Vasc Surg (2007) 0.91
Predicting vascular complications during transfemoral transcatheter aortic valve replacement using computed tomography: a novel area-based index. Catheter Cardiovasc Interv (2014) 0.90
Three-dimensional imaging in the context of minimally invasive and transcatheter cardiovascular interventions using multi-detector computed tomography: from pre-operative planning to intra-operative guidance. Eur Heart J (2010) 0.90
Utility of IVUS-guided transaccess catheter in the treatment of long chronic total occlusion of the superficial femoral artery. Catheter Cardiovasc Interv (2004) 0.90
Percutaneous valve procedures: an update. Curr Probl Cardiol (2008) 0.90